期刊文献+

巴斯德毕赤酵母表达的突变型人白细胞介素-2的发酵条件与纯化研究 被引量:8

Studies on Fermentation Conditions and Purification of Mutant Human Interleukin-2 Expressed in Pichia pastoris
下载PDF
导出
摘要 在以前的研究中,通过蛋白质工程技术获得了三突变体白细胞介素_2基因(编码12 5位半胱氨酸→丙氨酸;18位亮氨酸→蛋氨酸;19位亮氨酸→丝氨酸) ,并在毕赤酵母中加以表达。进一步优化表达条件,其最适诱导条件:80 %以上的通气,诱导2d ,初始pH6 0 ,甲醇终浓度为1 0 %。在上述条件下表达量占菌体总蛋白的30 %以上,大约2 0 0mg L。建立了一套从毕赤酵母表达上清中分离纯化分泌型表达蛋白IL_2的方法,经离心,超滤浓缩,强阳离子交换S柱和分子筛层析得到纯化的突变型和野生型IL_2 ;其得率为2 7% ,纯度达电泳纯并且HPLC检测只有一个峰。纯化的突变蛋白对CTLL_2细胞具有刺激性;与野生型IL_2相比,在各种温度条件下储存的突变蛋白保留有更高的活性;突变型IL_2的活力是野生型的4~5倍,具有更高的利用价值。 Interleukin-2 (IL-2) was initially isolated as a T cell growth factor and had been shown to direct the expansion and differentiation of several hematopoietic cell types. Clinical studies using IL-2 in the treatment of AIDS have been encouraging, due to its critical role as a proliferative signal for activated T-lymphocytes. IL-2 has also undergone trials in the treatment of several types of cancer, based on its stimulation of cytotoxic, antitumor cells. Today, human IL-2 is produced completely by genetically engineered method, and it has been proved that genetically engineered recombinant human IL-2 has almost the same function and clinical effect as wild IL-2. In the former study, recombinant human IL-2 usually comes from E.coli, in this paper the mutant IL-2 was successfully expressed and purified in Pichia pastoris for the first time. As a eukaryote, Pichia pastoris has many of the advantages of higher eukaryotic expression systems such as protein processing,protein folding, and posttranslational modification, while being as easy to manipulate as E.coli or Saccharomyces cerevisiae. It is faster, easier, and less expensive to use than other eukaryotic expression systems such as baculovirus or mammalian tissue culture, and generally gives higher expression level. Expression conditions of human mutant interleukin-2(the codon for cysteine-125 of human IL-2 with alanine; the codon for leucine-18 with methionine; the codon for leucine-19 with serine) in the recombinant Pichia pastoris strain were optimized via test of some factors such as the rate of aeration, the inductive duration, the initial pH and the concentration of methanol. The results from tests showed that the most important parameter for efficient expression of interleukin-2 in recombinant Pichia pastoris strain is adequate aeration during methanol induction, and the optimum inductive condition for interleukin-2 expression was: more than 80% aeration, 2 days for induction, the initial pH of 6.0, the final methanol concentration of 1.0%. With this condition, the expressed IL-2 was secreted into fermentation broth and reached a yield of 30%, approximately 200 mg/L. Expressed interleutin-2(MvIL-2) was isolated and purified by centrifugation, millipore filtration to concentration, Econo-PacS strongly acidic cation exchanger cartridge and molecular sieve chromatography and the yield of MvIL-2 was 27%. MvIL-2 was purified to electrophoretic purity by SDS-PAGE and only one peak being loaded on HPLC. Purified MvIL-2 protein had stimulating activity similar to the wild type of IL-2 as assayed by IL-2-dependent CTLL-2 cells. However, the stability of MvIL-2 was superior than that of IL-2 at different temperatures. The activity of obtained MvIL-2 was 4~5 times of the wild type of IL-2, So MvIL-2 had an advantage over wild type of rhIL-2 in storage stability and activity.
出处 《生物工程学报》 CAS CSCD 北大核心 2005年第3期430-434,共5页 Chinese Journal of Biotechnology
基金 西南师范大学科学基金项目~~
关键词 纯化 高效分泌表达 突变型人白介素-2 毕赤酵母 purification, secreted overexpression, human IL-2 mutant, Pichia pastoris
  • 相关文献

参考文献12

  • 1郭葆玉. Genetically Engineered Pharmacology.Shanghai: Second Military Medical University Press, 2000
  • 2Wang Y, Li L, Liu JF et al. Theanalytic domain of IL-2. Biochem Biophys Res, 1997, 230(3) :542 - 545
  • 3Weir MP, Sparks J, Chaplin AM. Micropreparative purification of recombinant human interleukin-2. Journal of Chromatography,1987, 396:209 - 215
  • 4Higgins DR, Cregg JM. Pichia protocols, Totowa, NJ: Humana Press Inc, 2001 ,pp. 134 - 136
  • 5刘堰,胡应和,欧阳克清,蔡绍皙.突变型人白细胞介素-2基因在巴斯德毕赤酵母中的表达[J].中国生物化学与分子生物学报,2003,19(5):618-624. 被引量:6
  • 6Multi-Copy Pichia Expression Kit Instruction Mannal. Invitrogen.com, 1996, pp.37-40;44-46
  • 7郭尧君. Protein Electrophoretic Technique. Beijing:Science Press, 1998
  • 8Bradford MM. A rapid and sensitve method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72:248 - 254
  • 9Dariusz S, Sarah J, Steer RH. An improved MTT assay. J Immunol Methods, 1993,157: 203 - 207
  • 10孙卫民,王惠琴. Methodology Studies on Cell Factors. Beijing: People Press, 1998

二级参考文献21

  • 1虞建良,范佩芳,郑宏大,孙兰英,王子轩,郑仲承,李伯良,陈寅,唐建伟,刘新垣.人白细胞介素-2在大肠杆菌高效表达及其纯化与鉴定[J].中国科学(B辑),1995,25(10):1063-1070. 被引量:4
  • 2张旭,黄秉仁,蔡良婉.白细胞介素-2的基因克隆及其在啤酒酵母细胞中的表达[J].中国医学科学院学报,1995,17(4):274-280. 被引量:1
  • 3唐建伟,刘爱萍,虞建良,范佩芳,刘新垣.两种新型白细胞介素-2的热稳定优越性[J].生物工程学报,1996,12(4):448-454. 被引量:8
  • 4Wang Y, Li L, Liu J F. The analytic domain of IL-2. Biochem Biophys Res, 1997, 230(3): 542-545.
  • 5Morgan D A, Ruscetti F W, Gallo R. Selective vitro growth of lymphacytes born normal human bonemarmws. Science, 1976, 193:1007.
  • 6Taniguchi T, Matsui H, Fujita T. Structure and expression of a cloned cDNA for human interleukin-2. Nature, 1983, 212:305 - 310.
  • 7Higgins D R, Cregg J M. Pichia protocols, Totowa, NJ. Humana Press Inc,2001:134 - 136.
  • 8Volmer P, Peters M, Elders M. Yeast expression of the cytokine receptor domain of the soluble interleukin-6 receptor. J Immunol Methods, 1996, 199: 47- 54.
  • 9Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning : A Laboratory Manual, 2nd ed. New York: CSHL Press, 1989: 16-340.
  • 10Pichia EasyComp^TM Kit (For the preparation and transformation of competent Pichia cells), USA: Invitrogen Corp,2000: 1 - 7.

共引文献5

同被引文献118

引证文献8

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部